Viking Global Investors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Viking Global Investors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,150,826	Closed	-$250M	–	108
2024 Q1	$250M	Hold	7,150,826	–	–	0.93%	34
2023 Q4	$272M	Hold	7,150,826	–	–	1%	34
2023 Q3	$131M	Buy	7,150,826 +511,627	+8%	+$10.7M	0.53%	46
2023 Q2	$172M	Hold	6,639,199	–	–	0.71%	46
2023 Q1	$125M	Hold	6,639,199	–	–	0.59%	42
2022 Q4	$164M	Buy	6,639,199 +1,333,333	+25%	+$39.2M	0.82%	39
2022 Q3	$95.2M	Hold	5,305,866	–	–	0.44%	58
2022 Q2	$60.2M	Hold	5,305,866	–	–	0.28%	64
2022 Q1	$118M	Hold	5,305,866	–	–	0.48%	55
2021 Q4	$232M	Hold	5,305,866	–	–	0.67%	44
2021 Q3	$177M	Hold	5,305,866	–	–	0.48%	58
2021 Q2	$146M	Hold	5,305,866	–	–	0.44%	52
2021 Q1	$106M	Hold	5,305,866	–	–	0.32%	65
2020 Q4	$175M	Hold	5,305,866	–	–	0.48%	52
2020 Q3	$95.5M	Buy	+5,305,866	New	+$96.1M	0.35%	62

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Viking Global Investors's INBX Position: Q2 2024 in Review

Viking Global Investors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 7,150,826 shares — an estimated $250M sold.

Viking Global Investors first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $272M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Viking Global Investors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Viking Global Investors sold 7,150,826 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $250M.
Viking Global Investors first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
Viking Global Investors's Inhibrx, Inc. Common Stock position peaked at $272M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Viking Global Investors's 13F filing for Q2 2024, filed 14 Aug 2024.